Literature DB >> 8497600

Imaging the postoperative neck.

P M Som1, M L Urken, H Biller, M Lidov.   

Abstract

The variety of cervical lymphadenectomy and neck reconstructive procedures that have been developed in the past 20 years has led to confusion about nomenclature in the literature. In addition, some of these operations result in gross alteration of the normal anatomy. The authors review the present classification system for cervical lymph nodes and various lymphadenectomy and reconstructive procedures. Examples of typical postoperative images are given. A protocol for postoperative follow-up is presented, which calls for imaging for 5 years after surgery. Finally, the authors review their experience with 400 cases, 276 of which were initially classified as having no clinical evidence of disease. Recurrence developed in 68 of these (in 62 [91%] within 4-18 months of surgery). Imaging findings altered the postoperative salvage plan in 17 (25%). Clinically occult disease was found at sectional imaging in 47 (17%).

Entities:  

Mesh:

Year:  1993        PMID: 8497600     DOI: 10.1148/radiology.187.3.8497600

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

1.  MR imaging of the muscular component of myocutaneous flaps in the head and neck.

Authors:  J Chong; L L Chan; H N Langstein; L E Ginsberg
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

Review 2.  Head and neck reconstructive surgery: what the radiologist needs to know.

Authors:  Faiz Syed; Matthew E Spector; Rebecca Cornelius; Ashok Srinivasan
Journal:  Eur Radiol       Date:  2016-01-20       Impact factor: 5.315

3.  Image fusion of thallium-201 SPECT and MR imaging for the assessment of recurrent head and neck tumors following flap reconstructive surgery.

Authors:  Noriaki Tomura; Osamu Watanabe; Koichi Omachi; Ikuo Sakuma; Satoshi Takahashi; Takahiro Otani; Hiroyuki Kidani; Jiro Watarai
Journal:  Eur Radiol       Date:  2003-10-03       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.